04/25/2024 6:18 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2024 8:52 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024 4:29 PM | Vistagen Therapeutics (Filer)
| Form PRE 14A | |
03/06/2024 5:00 PM | SAXE JON S (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:00 PM | Cunningham Ann Michelle (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:00 PM | Curley Joanne (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:00 PM | FitzPatrick Margaret M (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/06/2024 5:00 PM | GIN JERRY B (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:00 PM | Rotunno Mary L. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 11:15 PM | Vistagen Therapeutics (Filer)
| Form EFFECT | |
02/14/2024 5:18 PM | CITADEL ADVISORS LLC (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 7:56 AM | Point72 Asset Management, L.P. (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024 5:27 PM | StemPoint Capital LP (Filed by) Vistagen Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/03/2024 4:17 PM | Singh Shawn (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:19 PM | Adler Reid G. (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:09 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 3:44 PM | Vistagen Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 8:46 PM | Vistagen Therapeutics (Filer)
| Form 8-K/A | |
11/06/2023 3:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 7:14 PM | Prince Joshua S. (Reporting) Vistagen Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
10/16/2023 3:34 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/16/2023 3:37 PM | TCG Crossover GP II, LLC (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/16/2023 3:01 PM | CITADEL ADVISORS LLC (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/12/2023 3:04 PM | GREAT POINT PARTNERS LLC (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/06/2023 3:05 PM | COMMODORE CAPITAL LP (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
10/06/2023 3:05 PM | COMMODORE CAPITAL LP (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/05/2023 3:47 PM | Point72 Asset Management, L.P. (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G | |
10/02/2023 6:15 AM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/29/2023 3:26 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2023 7:43 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2023 4:27 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2023 12:08 PM | Anderson Cynthia Lynn (Reporting) Vistagen Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/23/2023 12:09 PM | Anderson Cynthia Lynn (Reporting) Vistagen Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2023 7:40 AM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 7:00 AM | Vistagen Therapeutics (Filer)
| Form 424B5 | |
08/07/2023 7:35 AM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/28/2023 3:54 PM | Vistagen Therapeutics (Filer)
| Form DEF 14A | |
07/28/2023 3:55 PM | Vistagen Therapeutics (Filer)
| Form DEFA14A | |
07/18/2023 5:02 AM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 3:35 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/07/2023 3:35 PM | BlackRock Inc. (Filed by) Vistagen Therapeutics (Subject)
| Form SC 13G/A | |
Log Into Marc's $5,000 System Today (Ad) New Panic Could Sweep America
Mark these words in 2024. Everyone's going to cash… Wall Street legend says: "A little-known vehicle outside of banks could double… triple… or even quadruple your life savings if you know where to find it right now." We urge you to move your cash into this vehicle in 2024. More here. |
06/28/2023 4:11 PM | Vistagen Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
06/28/2023 3:28 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 7:35 AM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2023 3:43 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 4:30 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2023 3:33 PM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2023 8:26 AM | Vistagen Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |